Recombinant Human VEGFD Protein，His

VEGFD (Vascular Endothelial Growth Factor D) is a member of the VEGF family, which plays a crucial role in the formation of blood vessels and lymphatic systems. Its primary function is to promote endothelial cell proliferation and survival, primarily in response to hypoxic conditions. Research into VEGFD has gained significance due to its implications in various physiological and pathological processes, including angiogenesis, lymphangiogenesis, and cancer progression. Elevated levels of VEGFD have been associated with several malignancies, where it contributes to tumor growth and metastasis by enhancing lymphatic vessel formation and facilitating tumor cell dissemination. Furthermore, its role in non-cancerous conditions like inflammation and tissue repair underscores its potential as a therapeutic target. Given the complexity of VEGF signaling pathways, ongoing studies are focused on elucidating VEGFD’s mechanisms of action, interactions with other molecules, and its regulatory networks within the tumor microenvironment. Recombinant VEGFD protein studies are particularly important as they provide insights into its biological functions and enable the development of diagnostic and therapeutic applications, potentially leading to novel treatments for diseases related to vascular dysregulation. The exploration of VEGFD's properties has implications for the understanding of not only cancer biology but also other conditions characterized by abnormal vascular growth, making it a vital area of inquiry in contemporary biomedical research.